Ocular Therapeutix Stock Analysis

Ocular Stock Analysis Notes

About 91.0% of the company shares are owned by institutional investors. The book value of Ocular Therapeutix was now reported as 0.79. The company recorded a loss per share of 1.29. Ocular Therapeutix had not issued any dividends in recent years. Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts. Ocular Therapeut operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 228 people. To find out more about Ocular Therapeutix contact Antony Mattessich at 781 357 4000 or learn more at https://www.ocutx.com.

Ocular Therapeutix Investment Alerts

Ocular Therapeutix Upcoming and Recent Events

Ocular Largest EPS Surprises

View All Earnings Estimates

Ocular Therapeutix Environmental, Social, and Governance (ESG) Scores

Ocular Stock Institutional Investors

Note, although Ocular Therapeutix's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Ocular Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.58 B.

Ocular Profitablity

The company has Profit Margin (PM) of (2.26) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.65) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.65.

Management Efficiency

Ocular Therapeutix has return on total asset (ROA) of (0.2237) % which means that it has lost $0.2237 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7267) %, meaning that it created substantial loss on money invested by shareholders. Ocular Therapeutix's management efficiency ratios could be used to measure how well Ocular Therapeutix manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.34. The value of Return On Capital Employed is expected to slide to -0.4. At this time, Ocular Therapeutix's Asset Turnover is quite stable compared to the past year.

Technical Drivers

As of the 2nd of December, Ocular Therapeutix holds the Coefficient Of Variation of 1721.22, risk adjusted performance of 0.0523, and Semi Deviation of 2.94. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Ocular Therapeutix, as well as the relationship between them. Please check Ocular Therapeutix jensen alpha and downside variance to decide if Ocular Therapeutix is priced some-what accurately, providing market reflects its current price of 9.89 per share. Given that Ocular Therapeutix has jensen alpha of (0.04), we recommend you to check out Ocular Therapeutix's recent market performance to make sure the company can sustain itself at a future point.

Ocular Therapeutix Price Movement Analysis

Ocular Therapeutix Insider Trading Activities

Ocular Therapeutix Outstanding Bonds

Ocular Therapeutix Predictive Daily Indicators

Ocular Therapeutix Corporate Filings

Ocular Therapeutix Forecast Models

Ocular Therapeutix's time-series forecasting models are one of many Ocular Therapeutix's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ocular Therapeutix's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Ocular Therapeutix prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ocular shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Ocular Therapeutix. By using and applying Ocular Stock analysis, traders can create a robust methodology for identifying Ocular entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Ocular analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Ocular analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Ocular Therapeutix stock analysis indicators help investors evaluate how Ocular Therapeutix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Ocular Therapeutix shares will generate the highest return on investment. By understating and applying Ocular Therapeutix stock analysis, traders can identify Ocular Therapeutix position entry and exit signals to maximize returns.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocular Therapeutix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For more information on how to buy Ocular Stock please use our How to buy in Ocular Stock guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocular Therapeutix. If investors know Ocular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocular Therapeutix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Ocular Therapeutix is measured differently than its book value, which is the value of Ocular that is recorded on the company's balance sheet. Investors also form their own opinion of Ocular Therapeutix's value that differs from its market value or its book value, called intrinsic value, which is Ocular Therapeutix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocular Therapeutix's market value can be influenced by many factors that don't directly affect Ocular Therapeutix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Ocular Therapeutix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocular Therapeutix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocular Therapeutix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.